COMPANY

Gel4Med

HQ: Brighton, MA source · gelformed.com ↗ · New England

FDA-cleared device company

Keywords: infectious disease

Location: Brighton, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

15NIH grants

Funding and NIH signals

NIH award NIH awarded $1M (SBIR Phase II 5R44AI143079-03, continuation, notice Jun 25, 2026). NIH RePORTER 5R44AI143079-03 (Jun 25, 2026)
Evidence (1 event)
- Jun 25, 2026 · NIH RePORTER 5R44AI143079-03
  Organization: GEL4MED, INC.; City/State: BRIGHTON, MA; Project number: 5R44AI143079-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-25; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Novel dermal templates for prevention and treatment of biofilms in cutaneous wounds; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Jun 25, 2026 Grant Government grant — SBIR: $1M (annual award, as published), announced Jun 25, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 17, 2025 Grant Government grant — SBIR: $1.05M (annual award, as published), announced Jun 17, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Funding

Last 2 years.

Jun 25, 2026 Government grant — SBIR: $1M (annual award, as published), announced Jun 25, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 17, 2025 Government grant — SBIR: $1.05M (annual award, as published), announced Jun 17, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

NIH awards 15

Annual award amounts. Total $9.0M.

Aug 29, 2024 NIH award 5R44DK137730-02 FY2024: $1,529,428 awarded for that fiscal year; activity R44 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Antimicrobial dermal matrices to promote infection f source ↗
Sep 7, 2023 NIH award 2SB1GM133305-04A1 FY2023: $1,200,000 awarded for that fiscal year; activity SB1 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Antimicrobial dermal matrices to promote infection source ↗
Aug 31, 2023 NIH award 1R44DK137730-01 FY2023: $1,119,996 awarded for that fiscal year; activity R44 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Antimicrobial dermal matrices to promote infection f source ↗
Jan 27, 2022 NIH award 3R44GM133305-03S1 FY2022: $50,000 awarded for that fiscal year; activity R44 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. TABA funding for the Fast Track project "ANTIMICROBIA source ↗
Mar 22, 2021 NIH award 5R44GM133305-03 FY2021: $980,093 awarded for that fiscal year; activity R44 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Antimicrobial dermal matrices to promote infection fre source ↗
Jan 25, 2021 NIH award 3R43EY031615-01S1 FY2021: $29,697 awarded for that fiscal year; activity R43 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Treatment of microbial keratitis and corneal wound he source ↗
Aug 14, 2020 NIH award 1R43AI155199-01 FY2020: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Antifungal Dermal Templates for Wound Healing source ↗
Jun 30, 2020 NIH award 1R43EY031615-01 FY2020: $380,007 awarded for that fiscal year; activity R43 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Treatment of microbial keratitis and corneal wound hea source ↗
Mar 26, 2020 NIH award 4R44GM133305-02 FY2020: $1,699,924 awarded for that fiscal year; activity R44 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Antimicrobial dermal matrices to promote infection f source ↗
Mar 28, 2019 NIH award 1R44GM133305-01 FY2019: $348,852 awarded for that fiscal year; activity R44 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Antimicrobial dermal matrices to promote infection fre source ↗
Mar 26, 2019 NIH award 1R43AI143079-01A1 FY2019: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Novel dermal templates for prevention and treatment source ↗
Sep 22, 2017 NIH award 1R43GM121127-01A1 FY2017: $292,475 awarded for that fiscal year; activity R43 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Management of bioburden and tissue regeneration in d source ↗
Aug 31, 2017 NIH award 1R43DK115347-01 FY2017: $298,530 awarded for that fiscal year; activity R43 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Therapeutic cells encapsulation and delivery for impro source ↗
Mar 14, 2017 NIH award 1R43GM122226-01 FY2017: $223,866 awarded for that fiscal year; activity R43 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Surgical Wound Closure Matrices for the Prevention of source ↗
May 6, 2016 NIH award 1R43GM117858-01 FY2016: $223,369 awarded for that fiscal year; activity R43 (SBIR); PI MEHTA, MANAV; recipient as written: GEL4MED, INC., BRIGHTON, MA. Flowable antimicrobial skin scaffolding matrix that pr source ↗